// App-Quantinova.ai

11522 : Derivation of gene expression classifiers for the non-invasive detection of bladder cancer in the hematuria and recurrence surveillance populations.

Researchers

Presenter

  • Karen B. Chapman

Principal Investigators

  • Ljubomir Buturovic

  • Liqun Qiu

  • Jennifer Kidd

  • Nadia Sheibani

  • Damjan Krstajic

  • Lyssa Friedman

  • James L. Bailen

  • Igor Dumbadze

  • Daniel R. Saltzstein

  • Matthew T. Olson

  • Neal D. Shore

Medical Centers

  • OncoCyte Corporation, Alameda, CA

  • Clinical Persona, Inc., East Palo Alto, CA

  • Clinical Persona, Inc., East Palo Alto, CA

  • First Urology Research, Louisville, KY

  • The Urology Group, Cincinnati, OH

  • Urology San Antonio, San Antonio, TX

  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD

  • Carolina Urologic Research Center, Myrtle Beach, SC

Locations

  • United States

Companies

  • OncoCyte Corporation

  • Clinical Persona, In

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final